Press releases

Start / Newsroom / Press releases

2018-01-18 14:07 SpectraCure to participate in a large research programme funded by Knut and Alice Wallenberg Foundation Regulatory MAR

2018-01-17 08:45 Patent for treatment consumable approved in Canada

2017-11-22 14:47 Results and strategies of the clinical studies were discussed with the responsible physician Regulatory

2017-11-13 15:35 PSA-values from clinical prostate trial mentioned on SpectraCure presentation at ”Stora Aktiedagen” in Stockholm Regulatory

2017-11-13 08:30 SpectraCure presents the company and the progress on their current clinical trial Regulatory

2017-11-08 15:49 The CEO of SpectraCure increases his shareholding through MK Capital

2017-10-18 09:54 Imaging material from clinical Phase 1 study Regulatory

2017-10-03 14:07 Concept study for next generation product completed Regulatory

2017-09-28 12:29 More preliminary results from the clinical Phase 1 study Regulatory

2017-09-06 09:31 Positive preliminary results from the clinical Phase 1 study are presented at a scientific conference Regulatory MAR